Just because you are exposed to a pathogen does not mean you will become sick. Increasingly, scientists have shown that genetics play a central role in determining whether the pathogens that cause a wide range of disease—including influenza, warts, and COVID-19—end up causing serious diseases.

Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering. Because current treatments for TB involve long courses of antibiotics, which are known to disrupt the balance of microbes in the gut, a better understanding of these interactions may help in predicting outcomes to therapy and suggest ways to improve it.

A 4-month daily regimen of rifapentine and moxifloxacin was noninferior to the standard 6-month regimen for tuberculosis treatment among people with HIV enrolled in a phase 3 clinical trial, researchers reported at CROI.

Multidrug-resistant tuberculosis (MDR-TB) was declared a public health crisis by the World Health Organization (WHO) in 2013 and each year continues to pose a serious threat to millions, especially to those infected with HIV. TB is one of the top 10 causes of death worldwide, and 15% of HIV-associated tuberculosis (TB) deaths were caused by MDR-TB in 2018. Furthermore, HIV patients are 20 times more likely to develop active TB than those without HIV.

To commemorate the International Women's Day, 8 March 2021, the World Health Organization and the Global Coalition of TB Activists conducted a webinar, #ChooseToChallenge: A Gender-Sensitive & Equitable Response to End TB.

The World Health Organization (WHO) will host a webinar on 16 March 2021 to provide an overview of planned updates to WHO TB policy guidance in 2021, promote an exchange of views on how to effectively address emerging needs of Member States for policy, and deliberate on key actions needed to enhance the implementation and evaluation of global TB policy guidance.

The International Journal of Tuberculosis and Lung Disease (IJTLD) is the official publication of the International Union Against Tuberculosis and Lung Disease (The Union).

On International Women’s Day, 8 March 2021, the Stop TB Partnership marked the vital role that women in all their diversity play in the global fight to end TB and in the overall global health arena. The Stop TB Partnership supported the launch of the TBWomen network and their 2021-2025 strategic plan and also launched a new position paper by Stop TB Partnership's TB REACH on 'Gender and TB'.

Researchers have identified a critical mechanism that allows deadly bacteria to gain resistance to antibiotics.

Antiretroviral treatment (ART) reduces the risk of developing active tuberculosis (TB) in people also infected with HIV-1, by dampening the activation of the body’s immune response. These findings could help improve treatment for both conditions in the future.